inner-banner-bg

International Journal of Clinical and Medical Education Research(IJCMER)

ISSN: 2832-7705 | DOI: 10.33140/IJCMER

Impact Factor: 1.76

Prostate Carcinoma, what would be the best to do ?

Abstract

Manfred Doepp

Diagnosis and treatment of prostate cancer is a controversial topic. An ideal clarity has not been found to date. This concerns screening, risks, genetics as well as therapy. Another issue is the differential diagnosis to prostatitis. The aim should be freedom from schemata and instead strict individualization. to this end, it is important not to set a standard in terms of lowering testosterone to zero. There is a lack of age-related normal ranges for this purpose. If these exist, the real free testosterone can be individually brought into the normal range, which would eliminate an important risk factor.

PDF